Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $49.58 million. The enterprise value is -$62.87 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.16 million shares outstanding. The number of shares has increased by 40.42% in one year.
Current Share Class | 86.16M |
Shares Outstanding | 86.16M |
Shares Change (YoY) | +40.42% |
Shares Change (QoQ) | +0.80% |
Owned by Insiders (%) | 4.44% |
Owned by Institutions (%) | 31.91% |
Float | 45.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.42 |
Forward PS | 3.00 |
PB Ratio | 0.21 |
P/TBV Ratio | 0.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.70, with a Debt / Equity ratio of 0.22.
Current Ratio | 11.70 |
Quick Ratio | 11.45 |
Debt / Equity | 0.22 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.49% and return on invested capital (ROIC) is -7.17%.
Return on Equity (ROE) | -10.49% |
Return on Assets (ROA) | -5.59% |
Return on Invested Capital (ROIC) | -7.17% |
Return on Capital Employed (ROCE) | -9.86% |
Revenue Per Employee | $765,987 |
Profits Per Employee | -$146,293 |
Employee Count | 150 |
Asset Turnover | 0.35 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.79 million in taxes.
Income Tax | 1.79M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.35% in the last 52 weeks. The beta is 1.78, so IPSC's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | -82.35% |
50-Day Moving Average | 0.53 |
200-Day Moving Average | 0.99 |
Relative Strength Index (RSI) | 51.24 |
Average Volume (20 Days) | 976,351 |
Short Selling Information
The latest short interest is 2.41 million, so 2.80% of the outstanding shares have been sold short.
Short Interest | 2.41M |
Short Previous Month | 2.56M |
Short % of Shares Out | 2.80% |
Short % of Float | 5.34% |
Short Ratio (days to cover) | 3.37 |
Income Statement
In the last 12 months, IPSC had revenue of $114.90 million and -$21.94 million in losses. Loss per share was -$0.26.
Revenue | 114.90M |
Gross Profit | 4.50M |
Operating Income | -29.68M |
Pretax Income | -131.64M |
Net Income | -21.94M |
EBITDA | -16.38M |
EBIT | -29.68M |
Loss Per Share | -$0.26 |
Full Income Statement Balance Sheet
The company has $165.12 million in cash and $52.68 million in debt, giving a net cash position of $112.45 million or $1.31 per share.
Cash & Cash Equivalents | 165.12M |
Total Debt | 52.68M |
Net Cash | 112.45M |
Net Cash Per Share | $1.31 |
Equity (Book Value) | 240.44M |
Book Value Per Share | 2.79 |
Working Capital | 155.13M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$114.51 million and capital expenditures -$90,000, giving a free cash flow of -$114.60 million.
Operating Cash Flow | -114.51M |
Capital Expenditures | -90,000 |
Free Cash Flow | -114.60M |
FCF Per Share | -$1.33 |
Full Cash Flow Statement Margins
Gross margin is 3.91%, with operating and profit margins of -25.83% and -19.10%.
Gross Margin | 3.91% |
Operating Margin | -25.83% |
Pretax Margin | -17.54% |
Profit Margin | -19.10% |
EBITDA Margin | -14.26% |
EBIT Margin | -25.83% |
FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -40.42% |
Shareholder Yield | -40.42% |
Earnings Yield | -44.26% |
FCF Yield | -231.16% |
Analyst Forecast
The average price target for IPSC is $3.33, which is 478.73% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.33 |
Price Target Difference | 478.73% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -1.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.3 |
Piotroski F-Score | 2 |